External Peer Review For Major Rulemakings Urged By OMB
This article was originally published in The Tan Sheet
Executive Summary
FDA rulemaking could be slowed in the wake of an Office of Management & Budget directive recommending all "economically significant" federal agency regs undergo an external peer review process.